BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (BTAI)

Historical Holders from Q1 2025 to Q3 2025

Symbol
BTAI on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
19.8M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
2.36M
Holdings value
$6.05M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
34
Number of buys
22
Number of sells
-10
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (BTAI)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
INTEGRATED CORE STRATEGIES (US) LLC 5.2% $3.49M 1.03M Millennium Management LLC 29 Sep 2025
ARMISTICE CAPITAL, LLC 4.99% -50% $522K -$8.52M 288K -94.2% Armistice Capital, LLC 31 Mar 2025

Institutional Holders of BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (BTAI)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 2.36M $6.05M +$4.55M $2.56 34
2025 Q2 603K $1.09M +$396K $1.81 33
2025 Q1 379K $770K +$770K $2.03 30